... San Francisco demonstrate that patients with acute myeloid leukemia (AML) who were treated with VIDAZA (azacitidine) ... care regimens (CCR). AML is a cancer of myeloid blood cells where abnormal cells ...
SAN FRANCISCO, Dec. 17 (UPI) -- A French-led international study suggests acute myeloid leukemia patients treated with Vidaza (azacitidine) have significantly increased overall survival.
... first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome. Dr. ...
... predict the risk of relapse in many adults diagnosed with acute myeloid leukemia (AML). All patients in the study ... patients under age 60 whose leukemia cells had normal-looking chromosome. The cells ...
... blood cancers known as mixed lineage leukemias (MLL) and how the disease might be treated, according to a study ... programmed cells all developed AML (acute myeloid leukemia) in five to seven weeks, even ...
... a particular anticancer drug. The findings, from a Cancer and Leukemia Group B clinical cooperative group ... retrospective study shows that people with acute myeloid leukemia (AML) whose leukemic cells ...
... for distinguishing cancer subtypes. MLL rearrangements have been observed in some cases of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). ALL patients with rearranged MLL have a ...
... new mouse models for human acute myeloid leukemia (AML), an aggressive and devastating cancer ... camera. Within weeks, the mice developed leukemias that showed the same genetic and pathological features ...
... of a molecule called miR-29b in acute myeloid leukemia (AML) cells can reverse gene changes that ... "It shows that putting this miR back into leukemia cell lines and leukemia cells from patients causes a ...
Researchers have designed new mouse models of human acute myeloid leukemia that accurately predict chemotherapy response in patients. The models precisely recapitulate genetic associations that have ...
Boosting the level of a molecule called miR-29b in acute myeloid leukemia cells can reverse gene changes that trap the cells in an immature, fast growing state of development. The ...
... receptor we now know is expressed in acute myeloid leukemia (AML) cells called Tropomyosin ... long-term survival with no presence of leukemia cells.
They also found AZ23 to be more effective in human AML ...
... and poor-risk but not good-risk acute myeloid leukemia in first complete remission, compared with ... of JAMA.
The optimal curative treatment of acute myeloid leukemia (AML) in first complete remission ...
... relapse-free survival benefit among adult patients with intermediate- and poor-risk but not good-risk acute myeloid leukemia in first complete remission, compared with nonallogeneic ...
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer. The study, published by Cell ...
